SeaStar Medical

1.64
-0.13 (-7.34%)
At close: Mar 04, 2025, 11:28 AM

SeaStar Medical Income Statement

Year FY23 FY22 FY21 FY20
Revenue n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a
Operating Income -14.21M -11.61M -4.45M -6.45M
Interest Income n/a 630.00 212.00 3.31K
Pretax Income -26.23M -23.01M -4.6M -3.27M
Net Income -26.23M -23.01M -4.6M -3.28M
Selling & General & Admin 8.04M 6.6M 1.68M 2.43M
Research & Development 5.97M 2.82M 2.77M 4.03M
Other Expenses 200K n/a 91K 84K
Operating Expenses 14.21M 11.61M 4.45M 6.45M
Interest Expense 1.08M 630K 212K 3.31M
Selling & Marketing Expenses 32K n/a n/a n/a
Cost & Expenses 14.21M 11.61M 4.45M 6.45M
Income Tax n/a 1K -1K 9K
Shares Outstanding (Basic) 866K 328K 289K 120.67K
Shares Outstanding (Diluted) 866.81K 328.45K 289.55K 120.67K
EPS (Basic) -30.29 -70.16 -15.9 -27.15
EPS (Diluted) -30.26 -70.07 -15.87 -27.15
EBITDA -11.14M -11.61M n/a n/a
Depreciation & Amortization 14.01M 11.61M 4.45M 6.45M